APIMEDS PHARMACEUTICALS US, INC. Repayments of Related Party Debt
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Repayments of Related Party Debt of $343.80 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-05-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2026-05-04
- APIMEDS PHARMACEUTICALS US, INC. repayments of related party debt for the quarter ending 2025-12-31 was $250.00K.
- APIMEDS PHARMACEUTICALS US, INC. repayments of related party debt for the quarter ending 2025-09-30 was $0.00.
- APIMEDS PHARMACEUTICALS US, INC. repayments of related party debt for fiscal 2025 was $343.80K.
- APIMEDS PHARMACEUTICALS US, INC. repayments of related party debt for fiscal 2023 was $31.90K.
| Period end | Repayments of Related Party Debt | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-04 | $250.00K derived: sum of 2 quarters · filed 2026-05-04 | $343.80K 10-K · filed 2026-05-04 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $93.80K 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $93.80K 10-Q · filed 2025-08-19 | ||||
| 2023-12-31 | $31.90K 10-K · filed 2025-04-15 | ||||
| 2023-03-31 | $31.90K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |